Pulmonary Alveolar Proteinosis (PAP) is a rare lung disease. In PAP, grainy material builds up in the air sacs (alveoli) of the lungs. This grainy material is made up of substances that normally are part of the coating of the alveoli. Healthy lungs contain a small amount of this material, called surfactant, which normally helps the lungs expand during breathing. However, in PAP, there is excessive buildup of this material, which makes it harder for the lungs to absorb oxygen. This leads to breathing problems, which can be severe. In addition, many PAP patients get secondary infections.
The Pulmonary Alveolar Proteinosis (PAP) program offers comprehensive evaluation and management of PAP. Under our care, people with PAP can lead active lives.
Rapid initial consultation with physicians who are experts in Pulmonary Alveolar Proteinosis and who have extensive experience treating patients with this rare condition
Frequent follow-up with the same physicians
Cutting edge diagnostic testing to confirm the diagnosis of PAP and determine its cause
Various treatment options tailored to the individual patient and disease severity, including whole lung lavage, inhaled GM-CSF, and immunosuppression if indicated
Patient education on the causes of Pulmonary Alveolar Proteinosis
Pulmonary rehabilitation programs
Care integrated with opportunities to participate in cutting edge research as part of the Rare Lung Diseases Consortium
Care integrated with patient support from the Pulmonary Alveolar Proteinosis Foundation.
To make an appointment in the PAP clinic, make an appointment online or call 1.877.CALL.NJH (877.225.5654) and ask to be scheduled to see Dr. Rachel L. Zemans.
If you have questions about the Pulmonary Alveolar Proteinosis program or would like to refer a patient, please email Rachel L. Zemans, MD, at email@example.com.